Imaging test for a brain tumor before surgery
Part of Cancer clinical trials.
This trial tests a new imaging method that uses a special dye to highlight a protein called Trop-2 found on some brain tumor cells. The goal is to see if this dye can help doctors see the tumor more clearly before surgery, which may improve surgical planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain tumor that doctors think is a craniopharyngioma, or it has been confirmed by a biopsy
- You are scheduled to have surgery to remove the tumor
- You are generally in good health, able to care for yourself and do daily activities
- You do not have other serious brain conditions like a stroke or Parkinson's
- Your liver and kidneys are working well enough
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging method (68Ga-DOTA-mPNE PET/CT) to see if it can help detect cancers. It's for people who haven't had chemotherapy or radiation yet and will have a biopsy or surgery.
This trial tests a new imaging agent (99mTc-CNDG) to see if it can help doctors see brain tumors better on a SPECT/CT scan. It might provide more information than standard scans and could help guide treatment decisions.
This trial tests a new imaging agent (99mTc-MY6349) to see if it can detect Trop2, a protein found on some breast cancer cells. It may help doctors better see and understand triple-negative breast cancer that has spread.
This trial uses a special PET scan to see if a new imaging agent can find hard-to-treat pituitary tumors that have come back after surgery. It may help doctors decide the best way to manage these tumors.
This early-phase study tests special PET/CT scans using a radioactive tracer to see cancer areas that have specific targets. It may help doctors better visualize tumors and plan next steps, using scans that you may already be familiar with (FDG) plus targeted tracers.
This trial tests a new imaging tracer called TATE-RGD to see if it can better spot certain tumors when used with a standard PET/CT scan. If you have cancer, you may be able to help by getting two scans a week apart.
Hear when a new Craniopharyngioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.